136 related articles for article (PubMed ID: 30297263)
1. Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer.
Sales MVC; Suemoto CK; Apolinario D; Serrao V; Andrade CS; Conceição DM; Amaro E; de Melo BAR; Riechelmann RP
Clin Colorectal Cancer; 2019 Mar; 18(1):19-27. PubMed ID: 30297263
[TBL] [Abstract][Full Text] [Related]
2. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of a Modified FLOX Adjuvant Regimen for Patients With Stage III Colorectal Cancer Treated in the Community.
Protásio BM; Matutino A; Lage LV; Santana I; Ramos R; Sabbaga J; Capareli F; Saragiotto D; Riechelmann R; Hoff PM
Clin Colorectal Cancer; 2017 Mar; 16(1):65-72. PubMed ID: 27515842
[TBL] [Abstract][Full Text] [Related]
5. Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study.
Andreis F; Ferri M; Mazzocchi M; Meriggi F; Rizzi A; Rota L; Di Biasi B; Abeni C; Codignola C; Rozzini R; Zaniboni A
Support Care Cancer; 2013 Feb; 21(2):583-90. PubMed ID: 22886390
[TBL] [Abstract][Full Text] [Related]
6. Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy.
Soveri LM; Lamminmäki A; Hänninen UA; Karhunen M; Bono P; Osterlund P
Acta Oncol; 2019 Apr; 58(4):398-406. PubMed ID: 30638100
[TBL] [Abstract][Full Text] [Related]
7. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
[TBL] [Abstract][Full Text] [Related]
9. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
[TBL] [Abstract][Full Text] [Related]
10. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?
Madbouly KM; Hussein AM; Zeid A
Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396
[TBL] [Abstract][Full Text] [Related]
11. Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting.
Moreau LC; Rajan R; Thirlwell MP; Alcindor T
Anticancer Res; 2013 Apr; 33(4):1765-8. PubMed ID: 23564831
[TBL] [Abstract][Full Text] [Related]
12. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB
Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161
[TBL] [Abstract][Full Text] [Related]
13. Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials.
Schmoll HJ; Twelves C; Sun W; O'Connell MJ; Cartwright T; McKenna E; Saif M; Lee S; Yothers G; Haller D
Lancet Oncol; 2014 Dec; 15(13):1481-1492. PubMed ID: 25456367
[TBL] [Abstract][Full Text] [Related]
14. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
Fontana E; Meyers J; Sobrero A; Iveson T; Shields AF; Taieb J; Yoshino T; Souglakos I; Smyth EC; Lordick F; Moehler M; Giraut A; Harkin A; Labianca R; Meyerhardt J; André T; Boukovinas I; Lonardi S; Saunders M; Vernerey D; Oki E; Georgoulias V; Ben-Aharon I; Shi Q
J Clin Oncol; 2021 Dec; 39(36):4009-4019. PubMed ID: 34752136
[TBL] [Abstract][Full Text] [Related]
15. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G
Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767
[TBL] [Abstract][Full Text] [Related]
16. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
Hompes D; D'Hoore A; Van Cutsem E; Fieuws S; Ceelen W; Peeters M; Van der Speeten K; Bertrand C; Legendre H; Kerger J
Ann Surg Oncol; 2012 Jul; 19(7):2186-94. PubMed ID: 22395983
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on safety and preliminary efficacy of dose-modified regimen of 5-fluorouracil plus oxaliplatin and irinotecan (FOLFOXIRI) in advanced colorectal cancer].
Cai Y; Deng R; Hu H; Zhang J; Ling J; Wu Z; Yang L; Li J; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1045-1050. PubMed ID: 30269326
[TBL] [Abstract][Full Text] [Related]
18. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
19. Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.
Vardy JL; Dhillon HM; Pond GR; Renton C; Dodd A; Zhang H; Clarke SJ; Tannock IF
Ann Oncol; 2016 Sep; 27(9):1761-7. PubMed ID: 27443634
[TBL] [Abstract][Full Text] [Related]
20. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
